OTC Stock Picks Carries an Investor's Alert on Awesome Penny Stocks - AEGY, FARE, AMBS, ADXS

Stamford, CT -- (SBWIRE) -- 01/29/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. These are the awesome penny stocks that the ‘underground penny stock experts’ brag about in our penny stock blogs.

Alternative Energy Partners Inc (OTC:AEGY) percentage change reduced -12.50% to close at $0.0007 with the total traded volume of 20.79 million shares, more than average volume of 4.45 million.

The Company’s year to date performance remained adverse with the decline of -30%. If we look at the last 6 months of trade, that is in the bearish zone with a drop of -88.33%

Its earnings per share was $-0.01. The company has the total of 209.62 million outstanding shares and its total market capitalization is $146,734.

Has AEGY Found The Bottom and is now Ready To Move Up? Find Out Here

Net Profits Ten Inc (OTC:FARE) started its trading session with the price $0.11 and closed at $0.0850 by decreasing -20.93%. Day trading range of AVNR was $0.08 -$0.11.

A review of its graph:
Previous 5 days graph demonstrated a positive move of 173.31%. FARE’s quarterly performance remained in the red -43.33%, while its year to date performance showed that the stock plunged overall -51.35%.

FARE’s stocks traded with total volume of 20.39 million shares, while the average trading capacity remained 39.02 million shares.

Why Should Investors Buy FARE After the Recent Fall? Just Go Here and Find Out

AMARANTUS BIOSCIENCES INC (OTC:AMBS), during the previous trading session, showed a negative movement of -7.28%.

Graph values of the stock demonstrate these trends: Year to date performance of the stock remained negative with the decline of -35.38%. AMBS traded with volume of 7.83 million shares, while its average trading volume remained 20.61 million shares.

Currently, the company has a market capitalization of $20.63 million. The stock’s closing price was $0.0853, while it started its day-trade at $0.09.

Amarantus BioScience, Inc., a biotechnology company developing and discovering treatments and diagnostics for diseases allied with the neurodegeneration and apoptosis centered on its patented therapeutic protein MANF, launched its new website at amarantus.com.

Will AMBS Get Buyers Even After The Recent Rally? Find Out Here

Advaxis, Inc. (OTC:ADXS) opened at $0.07 and, as day trade closed, its price was $0.0730 after scoring 8.96% .The market capitalization of ADXS was $28.64 million. Total traded volume of the stock was 7.69 million shares, while the company’s average volume remained 4.85 million shares.

ADXS’s day range remained $0.06 - $0.07, while its 52 week range was $0.03 - $0.17. During the last 5 trades, the stock jumped almost 4.29%. During the last 3 months it rose 60.44%. Its year to date performance remained progressive 143.33%.

Has ADXS Found The Bottom And Ready To Gain Momentum? Find Out Here

About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.

Disclaimer
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.